Cargando…
Waning Humoral Response after COVID-19 mRNA Vaccination in Maintenance Dialysis Patients and Recovery after a Complementary Third Dose
The aim of this study was to analyze the waning of anti-spike (S) antibodies after mRNA vaccination against COVID-19 in maintenance dialysis patients, and to assess the safety and effectiveness of the complementary third dose. This was a prospective, longitudinal study in which we analyzed the kinet...
Autores principales: | Biedunkiewicz, Bogdan, Tylicki, Leszek, Ślizień, Waldemar, Lichodziejewska-Niemierko, Monika, Dąbrowska, Małgorzata, Kubanek, Alicja, Rodak, Sylwia, Polewska, Karolina, Tylicki, Piotr, Renke, Marcin, Dębska-Ślizień, Alicja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950255/ https://www.ncbi.nlm.nih.gov/pubmed/35335065 http://dx.doi.org/10.3390/vaccines10030433 |
Ejemplares similares
-
Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project
por: Polewska, Karolina, et al.
Publicado: (2021) -
Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine
por: Piotrowska, Magdalena, et al.
Publicado: (2022) -
Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study—The COViNEPH Project
por: Dębska-Ślizień, Alicja, et al.
Publicado: (2021) -
Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant Recipients
por: Ślizień, Zuzanna, et al.
Publicado: (2022) -
Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients
por: Tylicki, Leszek, et al.
Publicado: (2021)